MusclePharm Corporation: 10-Q filed 2014-08-05
What MusclePharm Corporation reported in its quarterly report filed 2014-08-05 (fiscal Q2 2014): 42 published measures, 113 facts as tagged in accession 0001144204-14-046854.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-05
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001144204-14-046854 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MusclePharm Corporation filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 66,932,918 | USD | |
| At 2013-12-31 | 52,157,696 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 28,839,495 | USD | |
| At 2013-12-31 | 32,423,160 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 38,093,423 | USD | |
| At 2013-12-31 | 19,734,536 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 408,328 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,144,562 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -2,421,808 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -9,783,789 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 2,401,182 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 307,760 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -78,682,855 | USD | |
| At 2013-12-31 | -81,827,417 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 10,610,022 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 10,459,522 | shares | 181 |
| 2013-04-01 to 2013-06-30 | 7,226,849 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 5,686,323 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 12,064,122 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 11,863,882 | shares | 181 |
| 2013-04-01 to 2013-06-30 | 7,226,849 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 5,686,323 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 0.04 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 0.3 | USD/shares | 181 |
| 2013-04-01 to 2013-06-30 | -0.34 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -1.72 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 0.03 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 0.27 | USD/shares | 181 |
| 2013-04-01 to 2013-06-30 | -0.34 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -1.72 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 44,786 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 76,947 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 0 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 0 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 6,221,261 | USD | |
| At 2013-12-31 | 2,613,584 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2,117,332 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 4,466,876 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 37,389 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 74,366 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 479,515 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,903,404 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -2,740,931 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -3,462,410 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 50,547,702 | USD | |
| At 2013-12-31 | 44,526,480 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 28,473,117 | USD | |
| At 2013-12-31 | 32,368,521 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 23,900,432 | USD | |
| At 2013-12-31 | 26,605,588 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 6,664,846 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 19,197,544 | USD | |
| At 2013-12-31 | 13,741,180 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 103,537 | USD | 181 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 15,167,248 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 30,616,428 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 10,654,272 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 19,540,512 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 19,769,356 | USD | |
| At 2013-12-31 | 15,772,368 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 15,646,763 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 33,519,832 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 7,913,341 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 16,078,102 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2,356,940 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 4,229,308 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 1,918,665 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,064,220 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 1,163,883 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,260,829 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 169,231 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 259,361 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 10,612,912 | shares | |
| At 2013-12-31 | 9,089,490 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 118,259,128 | USD | |
| At 2013-12-31 | 103,064,901 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 4,665 | USD | |
| At 2013-12-31 | -14,042 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 45,600 | USD | |
| At 2013-12-31 | 2,562,502 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 8,216,809 | USD | |
| At 2013-12-31 | 3,974,575 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,995,548 | USD | |
| At 2013-12-31 | 1,360,991 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 6,732,532 | USD | |
| At 2013-12-31 | 155,165 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 179,632 | USD | |
| At 2013-12-31 | 144,229 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 366,378 | USD | |
| At 2013-12-31 | 54,639 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 4,527,085 | USD | |
| At 2013-12-31 | 2,053,101 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 453,114 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 3,221,509 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -2,421,808 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -9,783,789 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 646,673 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 333,383 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 293,113 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 578,295 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 0 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 0 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -26,401 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 318,105 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 319,123 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -6,321,379 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 4,790,307 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 5,713,366 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 3,155,989 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 170,254 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -2,664,980 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 80,187 | USD | 181 |
Inspect the source
- Entity
- MusclePharm Corporation / CIK 0001415684
- Captured
- SEC response SHA-256
468a04d5e93b916c24c9590128d034d873e433232d8fd2a3bf40cb8a957ad42c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001415684.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))